Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
Open Access
- 12 September 2021
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (5), 2974
- https://doi.org/10.15829/1728-8800-2021-2974
Abstract
Catheter ablation (CA) of atrial fibrillation and flutter is associated with a high risk of both perioperative thromboembolic events and bleeding. Adequate anticoagulation is imperative to reduce the risk of complications. The aim of this review was to analyze modern approaches to anticoagulant therapy for CA of atrial fibrillation and flutter, as well as provide practical information based on a comparison of current guidelines and evidence base. The search for literature sources on anticoagulant therapy in CA was carried out in the PubMed, Scopus, Web of Science databases. The results of key randomized trials and meta-analyzes are presented, and a comparison of current Russian and international guidelines is given. Unresolved issues requiring further research are discussed.Keywords
This publication has 27 references indexed in Scilit:
- An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablationHeart Rhythm, 2018
- Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial FibrillationThe New England Journal of Medicine, 2017
- New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interrupted or continuous warfarinJournal of Interventional Cardiac Electrophysiology, 2017
- Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter studyHeart Rhythm, 2015
- Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillationEuropean Heart Journal, 2015
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation ManagementJournal of the American College of Cardiology, 2014
- Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter studyHeart Rhythm, 2014
- Subtle Post-Procedural Cognitive Dysfunction After Atrial Fibrillation AblationJournal of Invasive Cardiology, 2013
- Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarinJournal of Interventional Cardiac Electrophysiology, 2012
- Neuropsychological decline after catheter ablation of atrial fibrillationHeart Rhythm, 2010